The Changing Landscape in Pediatric Hospitals: A Multicenter Study of How Pediatric Chronic Critical Illness Impacts

Renee D Boss1,2, Carrie M Henderson3,4, Elliott M Weiss5,6

  • 1Division of Neonatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Insights

Infants with chronic critical illness represent 35% of complex pediatric inpatients, often requiring intensive care and medical technology. Understanding their needs is crucial for effective hospital resource planning and bed management.

Area of Science:

  • Pediatric critical care medicine
  • Healthcare resource management
  • Medical technology utilization in pediatrics

Background:

  • Prolonged hospitalizations of children with medical complexity strain pediatric inpatient bed availability.
  • Infants with chronic critical illness (CCI) are a significant but poorly characterized patient group.
  • Accurate data on CCI infants is essential for effective resource allocation in intensive care units (ICUs) and general pediatric wards.

Purpose of the Study:

  • To describe the characteristics of infants with chronic critical illness.
  • To analyze hospitalization patterns and medical technology use in this population.
  • To inform resource planning for pediatric healthcare systems.

Main Methods:

  • Screening of infants admitted to six US academic medical centers.
  • Inclusion criteria based on prolonged/repeated hospitalizations, medical technology use, and multiorgan involvement.
  • Collection of patient and hospitalization data.

Main Results:

  • Infants (<12 months) constituted 34.8% of eligible chronic critical illness inpatients.
  • Nearly all infants used medical technology (97.8%) and had multiorgan involvement (94.8%).
  • Eighty-six percent spent time in an ICU; 78.2% were discharged with medical technology, often escalated upon readmission.

Conclusions:

  • Advanced strategies are needed for hospital resource allocation for infants with CCI.
  • These infants' care often transitions between neonatal ICUs, other ICUs, and general wards.
  • Early identification and tracking, starting in the neonatal ICU, are vital for anticipating and managing inpatient bed needs.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
127
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
105
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
159
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
138
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.9K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
143